InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,168.25
(
0.79%
)
US TECH 100
17,567.60
(
0.85%
)
Dow Jones
38,770.68
(
0.25%
)
Brent Oil
83.40
(
0.32%
)
Bitcoin
63,267.47
(
-1.14%
)
Post# of 216
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

TREND1

Send PM Follow Ignore
Followers 417
Posts 52354
Boards Moderated 13
Alias Born 12/16/2001

TREND1

Member Level

Re: None

Friday, 05/12/2017 11:44:45 AM

Friday, May 12, 2017 11:44:45 AM

Post# of 216
5/12 Mannkind Q1: Nothing But Losses

•The first quarter had losses of $16.3 million.

•The company made more money selling bulk insulin than their inhalable drug Afrezza.

•With no improvement in sales, I don't know how MannKind can stem its losses from continuing.



https://seekingalpha.com/article/4072614-mannkind-corp-nothing-losses?auth_param=1vat:1chbheb:1f209c2fbcc6e4f8348f309ff84c9019&uprof=51#alt3

MAIN BOARD http://investorshub.advfn.com/TRADING-3X-TNA-TQQQ-SPXL-RUS-2000-FUTURES-12981/

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up